Search

everythinglearnresearchcommunity

for

Search:↓

Autoimmune Polyendocrine Syndromes involve specific combinations of endocrine and non-endocrine autoimmune diseases.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

Managing severe infections in SLE patients requires tailored treatment strategies.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Most lupus patients in coastal Kerala had skin-specific lesions that could help diagnose the disease, and non-specific skin issues were linked to more severe, systemic lupus.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Doctors should consider SLE in males even if antinuclear antibody tests are negative.

A woman with lupus improved significantly from scalp hair loss after treatment, highlighting the need to identify psoriatic alopecia in lupus patients to avoid permanent hair loss.

Diagnosing new systemic lupus during pregnancy is hard but important for the health of the mother and baby.

Systemic lupus erythematosus is diagnosed earlier in males than females.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Most patients with Cutaneous Lupus Erythematosus are young females, and dermatologists play a key role in diagnosis.

Panchkarma treatment can help manage symptoms of Systemic Lupus Erythematous.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Black patients with discoid lupus erythematosus have more severe skin damage and higher chances of dyspigmentation, scalp, and ear involvement.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

People with lupus and rheumatoid arthritis have thinner hair than healthy people.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Most patients with cutaneous lupus erythematosus in Bangladesh are young women, with chronic forms and photosensitivity being common.